A phase II study of atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC) patients (pts) Meeting Abstract
| Authors: | Grünwald, V.; McDermott, D. F.; Atkins, M.; Motzer, R.; Rini, B.; Escudier, B.; Fong, L.; Joseph, R.; Pal, S. K.; Sznol, M. M. D.; Hainsworth, J. D.; Stadler, W.; Hutson, T. E.; Ravaud, A.; Bracarda, S.; Suarez-Rodriques, C.; Choueiri, T.; Choi, Y. J.; Huseni, M.; Fine, G.; Powles, T. |
| Abstract Title: | A phase II study of atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC) patients (pts) |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 40 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2017 Sep 29-Oct 3 |
| Meeting Location: | Stuttgart, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2017-09-01 |
| Start Page: | 113 |
| End Page: | 114 |
| Language: | English |
| ACCESSION: | WOS:000411428400283 |
| PROVIDER: | wos |
| PUBMED: | 28934740 |
| DOI: | 10.1159/000479566 |
| Notes: | Meeting Abstract: V419 -- Source: Wos |
